India's Claris in JV with Japan's Otsuka Pharma, Mitsui for drugs biz
MUMBAI (Reuters) - Indian drugmaker Claris Lifesciences Ltd (CLAI.BO) said on Friday it will form a joint venture with Japan's Otsuka Pharmaceutical Factory and Mitsui & Co Ltd (8031.T) for its medical infusion drugs business in India and emerging countries.
Claris said its board also approved the sale of its infusion business, on a slump basis, to the company's fully-owned unit, Claris Speciality Injectables, which will eventually run the joint venture.
(Reporting by Kaustubh Kulkarni in MUMBAI)
WASHINGTON - U.S. small business sentiment bounced back from a seven-month low in November, with owners setting their sights on creating more jobs and expanding operations.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.